COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
4.390
+0.080 (1.86%)
At close: Aug 8, 2025, 4:00 PM
4.350
-0.040 (-0.91%)
After-hours: Aug 8, 2025, 7:47 PM EDT
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $421.18 million as of August 8, 2025. Its market cap has decreased by -11.25% in one year.
Market Cap
421.18M
Enterprise Value
234.59M
1-Year Change
-11.25%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $421.18M, a decrease of -25.92%. That is a compound annual growth rate of -5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 421.18M | 62.85% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
| Sep 18, 2020 | 568.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |